text: Yo, listen up, I got a story to tell,
  'Bout microRNA and vascular inflammation hell.
  This study aimed to assess the expression profile,
  Of miRs in monocytes, a cellular biomarker trial.
  
  ST-segment elevation myocardial infarction,
  That's STEMI, the condition we're attackin'.
  Microarray techniques and TaqMan PCR,
  Global expression of 352 miRNAs, we declare.
  
  Peripheral blood monocytes, healthy donors we see,
  Twenty in total, patients with acute STEMI, twenty-four, gee.
  MiR-143 in STEMI patients showed an increase,
  While miR-1, -92a, -99a, -223 decreased, peace.
  
  In 3.5 plus or minus 1.5 months, the follow-up game,
  MiR-1 and -223 returned to baseline, no shame.
  MiR-92a and -99a took 3 months to normalize,
  But they still stayed lower than healthy controls, recognize.
  
  MiR-143 in monocytes had a positive correlation,
  With hs-CRP, inflammation's indication, no hesitation.
  But cTnT didn't show such a relationship,
  MiR-143 and hs-CRP, that's the membership.
  
  Now here's something important, pay attention, fam,
  INF-gamma treatment caused miR-143 an upslam,
  MiR-1 went down, when monocytes were the deal,
  LPS and TNF-alpha didn't have that kind of appeal.
  
  Our findings suggest monocytes as carriers anew,
  Biomarkers in circulation, that's a clue,
  In the early phase of myocardial infarction's wrath,
  Circulating monocytes, they light the path.